The effectiveness of borneol on pharmacokinetics changes of four ginsenosides in Shexiang Baoxin Pill in vivo

Biomedical Chromatography

Volumn 28, Issue 3, 2014, Pages 419-427

  Jiang, Peng ^a,b   Fu, Peng ^c   Xiang, Li ^a   Wang, Shuping ^a   Liu, Xiaojun ^a   Yang, Ling ^d   Tao, Jianfei ^e   Chen, Zhongliang ^b   Zhan, Changsen ^b   Huang, Ximing ^b   Liu, Runhui ^a   Zhang, Weidong ^a,d,f  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Shanghai Hutchison Pharmaceuticals Company   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^e Yangsi Hospital of Shanghai   (China)

^f SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Borneol; Ginsenoside; Pharmacokinetic; Rat plasma; Shexiang Baoxin Pill

Indexed keywords

MEDICINE; RATS;

BORNEOL; GINSENOSIDE RB1; GINSENOSIDE RE; GINSENOSIDE RG1; GINSENOSIDES; IN-VIVO; ORAL ADMINISTRATION; RAT PLASMA; SHEXIANG BAOXIN PILL; TRADITIONAL CHINESE MEDICINE;

PHARMACOKINETICS;

BORNEOL; CHINESE DRUG; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RC; GINSENOSIDE RE; GINSENOSIDE RG 1; SHEXIANG BAOXIN PILL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; RAT; TANDEM MASS SPECTROMETRY;

RATTUS;

BORNEOL; GINSENOSIDE; PHARMACOKINETIC; RAT PLASMA; SHEXIANG BAOXIN PILL;

ANIMALS; BORNANES; CHROMATOGRAPHY, LIQUID; DRUGS, CHINESE HERBAL; GINSENOSIDES; HERB-DRUG INTERACTIONS; LINEAR MODELS; MALE; MASS SPECTROMETRY; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84893784256     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.3037     Document Type: Article

References (30)

1. Bansal T, Mishra G, Jaggi M, Khar RK and Talegaonkar S. Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats. European Journal of Pharmaceutical Science 2009; 36: 580-590.
2. Cai ZW, Qian TX, Wong Ricky and Jiang ZH. Liquid chromatography-electrospray ionization mass spectrometry for metabolism and pharmacokinetic studies of ginsenoside Rg3. Analytica Chimica Acta 2003; 492: 283-293.
3. Chen W, Dang YJ and Zhu CY. Simultaneous determination of three major bioactive saponins of Panax notoginseng using liquid chromatography-tandem mass spectrometry and a pharmacokinetic study. Chinese Medicine 2010; 5: 12-17.
4. Chu Y, Zhang HC, Li SM, Wang JM, Wang XY, Li W, Zhang LL, Ma XH, Zhou SP, Zhu YH and Liu CX. Determination of ginsenoside Rc in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. Journal of Chromatography B Analytical Technology Biomedical Life Science 2013; 919-920: 75-78.
5. Cui JF, Björkhem I and Eneroth P. Gas chromatographic-mass spectrometric determination of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol for study on human urinary excretion of ginsenosides after ingestion of ginseng preparations. Journal of Chromatography B 1997; 689: 349-355.
6. Deng GF, Wang DL, Meng MX, Hu F and Yao TW. Simultaneous determination of notoginsenoside R1, ginsenoside Rg1, Re, Rb1 and icariin in rat plasma by ultra-performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 2009; 877: 2113-2122.
7. Hasegawa H, Sung JH, Matsumiya S and Uchiyama M. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Medica 1996; 62: 453-457.
8. He HJ, Shen Q and Li J. Effects of borneol on the intestinal transport and absorption of two P-glycoprotein substrates in rats. Archives of Pharmacal Research 2011; 34: 1161-1170.
9. Ji HY, Lee HW, Kim HK, Kim HH, Chang SG, Sohn DH, Kim J and Lee HS. Simultaneous determination of ginsenoside Rb1 and Rg1 in human plasma by liquid chromatography-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2004; 35: 207-212.
10. Jiang P, Dai WX, Yan SK, Chen ZL, Xu RL, Ding JM, Xiang L, Wang SP, Liu RH and Zhang WD. Biomarkers in the early period of acute myocardial infarction in rat serum and protective effects of Shexiang Baoxin Pill using a metabolomic method. Journal of Ethnopharmacology 2011a; 138: 530-536.
11. Jiang P, Dai WX, Yan SK, Chen ZL, Xu RL, Ding JM, Xiang L, Wang SP, Liu RH and Zhang WD. Potential biomarkers in the urine of myocardial infarction rats: a metabolomic method and its application. Molecular BioSystems 2011b; 7: 824-831.
12. Li L, Sheng Y, Zhang J, Wang C and Guo D. HPLC determination of four active saponins from Panax notoginseng in rat serum and its application to pharmacokinetic studies. Biomedical Chromatography 2004; 18: 849-856.
13. Li Q, Ye YH and Xing QY. Progress on the water-soluble constituents and its phamacology of Panax notoginseng. Chemical Research of Chinese University 1996; 17: 1886-1892.
14. Odani T, Tanizawa H and Takino Y. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. III, The absorption, distribution and excretion of ginsenoside Rb1 in the rat. Chemical and Pharmceutical Bulletin 1983a; 31: 1059-1066.
15. Odani T, Tanizawa H and Takino Y. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. II, The absorption, distribution and excretion of ginsenoside Rg1 in the rat. Chemical and Pharmceutical Bulletin 1983b; 31: 292-298.
16. Schwarz UI, Gramatté T, Krappweis J, Oertel R and Kirch W. P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans. International Journal of Clinical Pharmacology Therapy 2000; 38: 161-167.
17. Shang D, Han H, Zhao R, Zhao Y, Xiong S and Liu G. New method for high-performance liquid chromatographic separation and fluorescence detection of ginsenosides. Journal of Chromatography A 2001; 910: 367-372.
18. Shen W, Fan WH and Shi HM. Effects of shexiang baoxin pill on angiogenesis in atherosclerosis plaque and ischemic myocardium. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010; 30: 1284-1287.
19. Tawab MA, Bahr U, Karas M, Wurglics M and Schubert-Zsilavecz M. Degradation of ginsenosides in human after oral administration. Drug Metabolism and Disposition 2003; 31: 1065-1071.
20. Wang LJ, Luo XP and Wang Y. Evaluation on tolerability and safety of long-term administration with shexiang baoxin pill in patients with coronary heart disease of stable angina pectoris. Zhongguo Zhong Xi Yi Jie He Za Zhi 2008a; 28: 399-401.
21. Wang T, Yu XF, Qu SC, Xu HL, Han B and Sui DY. Effect of ginsenoside Rb3 on myocardial injury and heart function impairment induced by isoproterenol in rats. European Journal of Pharmacology 2010; 636: 121-125.
22. Wang Z, Li M, Wu WK, Tan HM and Geng DF. Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction. Cardiovascular Drugs Therapy 2008b; 22: 443-452.
23. Xu QF, Fang XL and Chen DF. Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats. Journal of Ethnopharmacology 2003; 84: 187-192.
24. Yuan J, Guo W, Yang B, Liu P, Wang Q and Yuan H. 16 cases of coronary angina pectoris treated with powder composed of radix ginseng, radix notoginseng and succinum. Journal of Traditional Chinese Medicine 1997; 117: 14-17.
25. + bone mesenchymal stem cells to the infarction heart in rats. Journal of Traditional Chinese Medicine 2011; 31: 203-208.
26. Zhang Y, Huo M, Zhou J and Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Computer Methods and Programs Biomedicine 2010; 99: 306-314.
27. Zhao J, Su C, Yang C, Liu M, Tang L, Su W and Liu Z. Determination of ginsenosides Rb1, Rb2, and Rb3 in rat plasma by a rapid and sensitive liquid chromatography tandem mass spectrometry method: Application in a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 2012; 64-65: 94-97.
28. Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q and Chen CJ. Mechanisms and clinical applications of ginseng root for cardiovascular disease. Medical Science Monitor 2004; 10: 187-192.
29. Zhou YQ, Li WZ, Chen LY, Ma SW, Ping L and Yang ZL. Enhancement of intestinal absorption of akebia saponin D by borneol and probenecid in situ and in vitro. Environmental Toxicology and Pharmacology 2010; 29: 229-234.
30. Zhu H, Luo XP and Wang LJ. Evaluation on clinical effect of long-term shexiang baoxin pill administration for treatment of coronary heart disease. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010; 30: 474-477.